Tumor necrosis factor-α and troponin I release in porcine cardiac lymph and coronary sinus blood before and after cardiopulmonary bypass

Lymphology

Volumn 35, Issue 3, 2002, Pages 105-113

  Vazquez Jimenez, J F ^a   Liakopoulos, O J ^a   Qing, Ma ^a   Messmer, B J ^a   Seghaye, M C ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; AORTA CLAMPING; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CYTOKINE RELEASE; FEMALE; HEART INFARCTION; HEART MUSCLE INJURY; HEART PROTECTION; LYMPH FLOW; LYMPH VESSEL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; CARDIOPULMONARY BYPASS; FEMALE; HEART INJURIES; LYMPH; LYMPHATIC SYSTEM; SWINE; TROPONIN I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036740727     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sadony, V, M Korber, G Albes, et al: Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 13 (1998), 57-65.
2. Kirklin, JK, S Westaby, EH Blackstone, et al: Complement and the damaging effects of cardiopulmonary bypass. J Thorac & Cardiovasc Surg 86 (1983), 845-857.
3. Faymonville, ME, J Pincemail, J Duchateau, et al: Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac & Cardiovasc Surg 102 (1991), 309-317.
4. Hennein, HA, H Ebba, JL Rodriguez, et al: Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac & Cardiovasc Surg 108 (1994), 626-635.
5. Balderman, SC, JN Bhayana, JJ Steinbach, et al: Perioperative myocardial infarction: a diagnostic dilemma. Ann Thorac Surg 30 (1980), 370-377.
6. Mehlhorn, U, KL Davis, EJ Burke, et al: Impact of cardiopulmonary bypass and cardioplegic arrest on myocardial lymphatic function. Am J Physiol 268 (1995), H178-H183.
7. Ullal, SR, TH Kluge, F Gerbode: Studies on cardiac lymph during extracorporeal circulation. Chest 61 (1972), 662-667.
8. Feola, M, G Glick. Cardiac lymph flow and composition in acute myocardial ischemia in dogs. Am J Physiol 229 (1975), 44-48.
9. Butler, J, GM Rocker, S Westaby: Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55 (1993), 552-559.
10. Yokoyama, T, M Nakano, JL Bednarczyk, et al: Tumor necrosis factor-a provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 95 (1997), 1247-1252.
11. Frering, B, I Philip, M Dehoux, et al: Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 108 (1994), 636-641.
12. Jansen, NJ, YJ Gu, L Eijsman, et al: Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 54 (1992), 744-747.
13. Menasche, P, S Haydar, J Peynet, et al: A potential mechanism of vasodilation after warm heart surgery. The temperature-dependent release of cytokines. J Thorac & Cardiovasc Surg 107 (1994), 293-299.
14. Kelly, RA, TW Smith: Cytokines and cardiac contractile function. Circulation 95 (1997), 778-781.
15. Wan, S, AP Yim: Cytokines in myocardial injury: Impact on cardiac surgical approach. Eur J Cardiothorac Surg 16 Suppl 1 (1999), S107-S111.
16. Adams, JE, GS Bodor, VG Davila-Roman, et al: Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 88 (1993), 101-106.
17. Vazquez-Jimenez, JF, MC Seghaye, Ma Qing, et al: Cannulation of the cardiac lymphatic system in swine. Eur J Cardiothorac Surg 18 (2000), 228-232.
18. Allen, SJ, HJ Geissler, KL Davis, et al: Augmenting cardiac contractility hastens myocardial edema resolution after cardio-pulmonary bypass and cardioplegic arrest. Anesthesia & Analgesia 85 (1997), 987-992.
19. Meldrum, DR: Tumor necrosis factor of the heart. Am J Physiol 274 (1998), R577-R595.
20. Wan, S, JM DeSmet, L Barvais, et al: Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac & Cardiovasc Surg 112 (1996), 806-811.
21. Saatvedt, K, H Lindberg, OR Geiran, et al: Complement activation and release of tumour necrosis factor alpha, interleukin-2, interleukin-6 and soluble tumour necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children. Scand J Clin & Lab Invest 55 (1995), 79-86.
22. Jansen, NJ, W van Oeveren, HM Oudemansvan Straaten, et al: Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac & Cardiovasc Surg 102 (1991), 515-525.
23. Michie, HR, KR Manogue, DR Spriggs: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318 (1988), 1481-1486.
24. Mair, J, I Wagner, B Morass, et al: Cardiac troponin I release correlates with myocardial infarction size. Eur J Clin Chem Clin Biochem 33 (1995), 869-872.
25. Gao, WD, D Atar, Y Liu, et al: Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 80 (1997), 393-399.
26. Huang, X, Y Pi, KJ Lee, et al: Cardiac troponin I gene knockout: A mouse model of myocardial troponin I deficiency. Circ Res 84 (1999), 1-8.
27. McDonough, JL, DK Arrell, JE Van Eyk: Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res 84 (1999), 9-20.